When it comes to cognitive behavior therapy (CBT) and most psychiatrists, a little knowledge is a troubling thing. We know that CBT is effective, but we don’t know how to practice it. We know that a lot of patients ask us about it, but we don’t know enough to confidently describe to them what it entails.

Neurontin (gabapentin) spends plenty of time in our patient’s medicine cabinets, but lately it has spent nearly as much time splashed across news sections of daily papers. Parke-Davis, the company that used to market Neurontin before it merged with Pfizer, has been accused of improperly promoting its use for a variety of off-label indications (1).

Dr. Pollack, as the head of the Anxiety Disorders Program at Mass General, you’ve had the opportunity to evaluate thousands of patients with panic disorder. Do have any practical tips for those of us with less experience?

Laura Duffy, M.D. is an Attending Psychiatrist at California Pacific Medical Center in San Francisco who was recently referred a patient with panic disorder whose anxiety was triggered in an unusual way.

Zyprexa (olanzapine) became rapidly popular after its introduction in the United States in 1996. Its structural similarity to Clozaril (clozapine) led to hopes that it would be as effective for treatment-resistant cases as Clozaril but without the risk of agranulocytosis.

Abilify (aripiprazole) is out! But you probably already know this, if your mailbox and fax machine have become as saturated with BMS-funded missives from CME, Inc. as mine have been. The hired guns are out in force once again, and so we front-line clinicians are faced with the task of separating the authentic wheat from the hyped-up chaff.

In the beginning of modern psychiatry, there was only one medication— Thorazine (Chlorpromazine). Thorazine was originally classified as an antihistamine, and was used to treat everything thrown in the path of psychiatrists: psychosis, mania, depression, and anxiety.

Dr. Jibson, how do you go about deciding which atypical antipsychotic to prescribe for a particular patient?

J.C. Michael Shea is Supervising Psychiatrist at Health and Education Services in Haverhill Massachusetts, and has treated many thousands of schizophrenic patients over a 30 year career. He has definitely hopped onto the Abilify bandwagon, and his perspective is an interesting one.

America has not been kind to St. John’s Wort. In Europe, this flowering bush that blooms around June 24 (St. John’s Day), has been all the rage for about 2000 years. It was first mentioned by the Roman Pliny the Elder in the first century, and over the past two millennia it has been used for a variety of ills, including diarrhea, urinary problems, demonic exorcism, and more recently, for melancholia.